tbuckley/cabot-search huggingface dataset:
Evaluation of <i>Bacillus anthracis</i> Contamination Inside the Brentwood Mail Processing and Distribution Center—District of Columbia, October 2001
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Guide for the Evaluation of Hearing Handicap
Journal: JAMA (1979)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Study of Primary Hyperaldosteronism
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diagnostic et traitement des maladies de la vésicule biliaire par l'excrétion vésiculaire provoquée (Epreuves de Meltzer-Lyon et de Stepp).
Journal: JAMA (1925)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Contents page + Editorial Board
Authors: Luciano Conti, Elena Cattaneo, Linda Overstreet, J Peter, H Burbach, Marten Smidt, Ole Jensen, John Lisman, Wickliffe Abraham, Anthony Robins, Helen Scharfman, Neil Maclusky, Christian Winkler, Deniz Kirik, Anders Bjo, Makoto Tsuda, Kazuhide Inoue, Michael Salter, Rosa Cossart, Christophe Bernard, Yehezkel Ben, Ari Trendsin, Sian Lewis, Heather Yeomans, Patrick Liu, Manager Moulton
Journal: Trends in Neurosciences (2005)
MENTAL DISEASES AND GENERAL PRACTICE.
Journal: JAMA (2006)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (Pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial
Authors: H. West, R. J. Belt, H. A. Wakelee, L. P. Bloss, L. Taylor, M. J. Monberg, Z. Ye, C. K. Obasaju
Journal: Journal of Clinical Oncology (2005)

7117 Background: P and G both have well demonstrated, single-agent activity in pts with locally advanced or metastatic NSCLC. This single cohort, phase II study was designed to determine the activity of the combination of P plus G when administered to pts with locally advanced or metastatic NSCLC. Methods: Pts with Stage IIIB- IV NSCLC have been enrolled. Treatment consisted of G 1250 mg/m2 administered over 30 minutes on D 1 and 8, with P 500mg/m2 administered over 10 minutes on D 8, immediately before G. Treatment was repeated every 21 days for a total of 6 cycles. All pts received folic acid, vitamin B12 and steroid prophylaxis. Results: To date, results are available for 47 pts (30 M/17 F). Median age was 65.0 (range = 43 - 82) years, ECOG PS 0 (36.2%), PS 1 (51.1%); Stage IIIB (10.6%), Stage IV (83.0%); Histology: non-squamous (76.5%), squamous (17.0%). Grade 3/4 hematologic and non-hematologic toxicities consisted of neutropenia (41.5%), thrombocytopenia (12.2%), dyspnea (22.0%), febrile neutropenia (12.2%), anemia (4.9%), fatigue (22.0%), nausea (12.2%), vomiting (9.8%), and rash (7.3%). Patients received a total of 144 cycles within the first 6 cycles, with a median of 3 cycles of treatment, with a median dose intensity of 82.2% for P and 78.9% for G. Response information is available for 34 patients: 1 CR, 14 PRs, 12 SDs, 7 PDs for an objective response rate of 44.1% (95%CI, 27.2%–62.1%). Conclusions: In this study, P + G had a disease control rate (ORR + SD) of 79.4% in the front-line treatment of NSCLC suggesting that this is an active doublet. Administering P on D 8 rather than D 1 does not seem to negatively impact the therapeutic index. Complete data, including updated survival and time to progression for all pts, will be available for presentation in May, 2005. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration Eli Lilly Eli Lilly Lilly Speaker Bureau Eli Lilly
Ursodeoxycholic acid response in primary biliary cholangitis is associated with a significant reduction in decompensation and mortality in compensated cirrhosis
Authors: Binu John, Nidah Shabbir Khakoo, Gabriella Aitcheson, Cynthia Levy, David Goldberg, Kalyan Ram Bhamidimarri, Maria Hernandez, Bassam Dahman, Yangyang Deng, Paul Martin, Tamar Taddei, David Kaplan
Journal: Journal of Hepatology (2020)
Polymicrobial bacteremia
Authors: G. A. Roselle
Journal: JAMA (1979)

Of 26,961 blood cultures taken during an 18-month period at the Cincinnati General Hospital, 1,715 (6%) were positive. Ninety-four patients had blood cultures containing more than one organism. Although aerobic and anaerobic streptococci were the most frequently isolated bacteria, a variety of microorganisms, including<i>Staphylococcus aureus</i>and the<i>Klebsiella-Enterobacter-Serratia</i>group, was isolated in different combinations depending on the underlying disease. Neurological illness, malignant neoplasms, burns, and decubitus ulcers were among the most common underlying conditions found. The overall mortality was 54%, but only 58% of these deaths were specifically related to an episode of polymicrobial bacteremia. Patient survival was significantly related to appropriate antimicrobial therapy. (<i>JAMA</i>242:2411-2413, 1979)
Étude multicentrique contrôlée sur l’évaluation d’un système d’e-learning pour le diagnostic de lésions gastriques en utilisant le narrow-band imaging avec grossissement (M-NBI).
Journal: Endoscopy (2017)

Le M-NBI est très utile pour le diagnostic de néoplasies gastriques superficielles (NGS). Cependant, son utilisation en routine ne peut se faire qu’avec de l’expérience qui s’acquiert avec du temps. Aussi, un système d’e-learning d’enseignement pour le diagnostic des NGS utilisant ce M-NBI a été développé.
Refined MD Anderson Prognostic Scoring System (MDAPS-R) for Chronic Myelomonocytic Leukemia (CMML)
Authors: Koichi Takahashi, Naveen Pemmaraju, Miloslav Beran, Alfonso Quintás-Cardama, Jorge E. Cortes, Farhad Ravandi, Stefan Faderl, Srdan Verstovsek, Tapan M. Kadia, Gautam Borthakur, Elias J. Jabbour, Naval Daver, Zeev Estrov, Sherry A. Pierce, Guillermo Garcia-Manero
Journal: Blood (2012)
AN EXPLANATION OF ORTHOSTATIC ALBUMINURIA
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Syphilis
Authors: G. Marshall Crawford
Journal: New England Journal of Medicine (1947)

WITH the termination of World War II and the return of several million young men to civilian life, the program for the control of syphilis is faced with a great problem. In spite of the lowest wartime venereal-disease rates for any nation in history, it is exceedingly important that consistent effort be maintained to eradicate syphilis. Even extremely efficient military supervision at separation centers cannot prevent the release of some cases of uncontrolled fresh infection. The cessation of large-scale effort by the armed forces requires increased public-health activity. Plans for the future in this respect, in addition to the continued . . .
Call for Participants
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Error in Figures and Table
Authors: Michael Fisch, Victor Chang
Journal: JAMA Oncology (2016)

and their oncology specialists embrace the transition to primary care settings or shared care, and not all primary care clinicians are comfortable caring for cancer survivors requiring complex care. 4Thus, while the CDC guideline related to chronic pain did not explicitly exclude cancer patients beyond active treatment, it clearly did not attempt to address the complicated issues of posttreatment cancer survivorship, nor were cancer specialists or palliative care specialists featured on the expert panel.Dr Meghani applauded our point that the way alternative chronic pain treatment approaches will be discussed, chosen, paid for, and monitored for long-term safety and efficacy outcomes remains unclear.She laments that in our current health care system, nonpharmacologic treatments (such as massage) are often difficult to access because of expense and inconsistent insurance coverage.The underlying issue with such therapies, however, is that their intermediate to longterm efficacy for treating chronic pain has not been established, as there is a paucity of methodologically rigorous trials in this realm. 5 Our call for investment in clinical research related to chronic pain in cancer survivors is one way to address the issue of access to promising therapies and devices that may contribute to the relief of suffering in this complex and vulnerable group of cancer survivors.
A New Service: Smithsonian Science Information Exchange, Inc.
Journal: JAMA (1972)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clinical trial of vaccine for type B hepatitis to begin next month
Authors: P. Gunby
Journal: JAMA (1979)

The first large-scale American trial of a vaccine for a sexually transmitted disease begins next month. The disease is type B hepatitis. The trial with the new vaccine will be among homosexual men. The go-ahead was given because of results from a just-completed study. This study, conducted in five large cities, indicates that sexually transmitted hepatitis B infections are far more common among homosexual men than has been suspected. Researchers found antibody titer evidence of previous hepatitis B infection in at least 45% of the homosexual men studied. In the San Francisco area, the rate was 58%. Based on those and other findings, the immunization trial will begin in April in at least five clinics. Two of these clinics, in Chicago and Los Angeles, are operated privately by homosexual groups to serve homosexual patients. The other three, in Denver, St Louis, and San Francisco, are public health clinics that serve
Massachusetts Medical Society
Authors: Hervey B. Elkins
Journal: New England Journal of Medicine (1957)

TOXIC HAZARDS*Modern Insecticides†II. Organic PhosphatesThe organic phosphates are second only to chlorinated compounds in importance as insecticides. In general, they are less selective in their action than the chlorinated insecticides and tend to be more toxic to warm-blooded animals, although a few members of the group are low in toxicity to mammals.The physiologic action of the organic phosphates is an irreversible inhibition of the cholinesterase molecules, resulting in an accumulation of large amounts of acetylcholine. A useful index of absorption of organic phosphates is the cholinesterase activity test, which may be carried out on the blood . . .
Implementation of Quarterly AIDS Map
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cadmium-Binding Proteins of Three Marine Molluscs and Characterization of Two Cadmium-Binding Glycoproteins from the Hepatopancreas of a Whelk, Buccinum tenuissimum
Authors: Yoshiko Dohi, Kikue Kosaka, Kunihiro Ohba, Yoshimasa Yoneyama
Journal: Environmental Health Perspectives (1986)
Does breast milk unleash gonadotropins?
Authors: F. R. Gonzalez
Journal: JAMA (1980)

Hormones continue to crop up in unexpected places. The detection of these powerful substances far from their presumed sites of origin is raising heretofore undreamed-of questions: How do catechol estrogens in the brain interact with biogenic amines, and could this interaction be implicated in the pathogenesis of disorders ranging from premenstrual tension to psychosis? What business do neurotransmitters have in the gastrointestinal tract? Is extrapancreatic insulin actually synthesized outside the pancreas (<i>JAMA</i>[MEDICAL NEWS] 242:1345, 1979), and if so, why? One of the "far-flung" hormones now under study is luteinizing hormone-releasing hormone (LH-RH), formerly thought to originate only in the hypothalamus and to act only on the anterior pituitary where it induces the production and release of these gonadotropins: LH, follicle-stimulating hormone (FSH), and human chorionic gonadotropin (HCG). This year, G. S. Khodr, MD, and T. M. Siler-Khodr, MD, of the Department of Obstetrics and Gynecology, University of Texas Health
Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?
Authors: G R Venning
Journal: BMJ (1983)

The process of discovery of 18 important adverse drug reactions was reviewed. For each adverse reaction the dates were noted of the report which first alerted the medical profession to the suspected reaction, the report which resulted in verification of causality beyond reasonable doubt, and the first regulatory action or warning to the medical profession in Britain by the Committee on the Safety of Medicines.